Envista Holdings Corp

NYSE NVST

Envista Holdings Corp Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 27, 2024: USD -59.80 M

Envista Holdings Corp Net Cash Used For Investing Activities is USD -59.80 M for the Trailing 12 Months (TTM) ending September 27, 2024, a -17.49% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Envista Holdings Corp Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 29, 2023 was USD -50.90 M, a 87.19% change year over year.
Envista Holdings Corp Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -397.40 M, a -1,181.94% change year over year.
Envista Holdings Corp Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending October 01, 2021 was USD -31.00 M, a 61.15% change year over year.
Envista Holdings Corp Net Cash Used For Investing Activities for the Trailing 12 Months (TTM) ending October 02, 2020 was USD -79.80 M, a 18.24% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

NYSE: NVST

Envista Holdings Corp

CEO	Mr. Paul A. Keel
IPO Date	Sept. 18, 2019
Location	United States
Headquarters	200 S Kraemer Blvd Bldg E
Employees	12,800
Sector	Health Care
Industries Dental Care Pharmaceuticals

Description

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.

Key trends

Past 5 years